Double vaccine test to evaluate the safety, tolerability and immunogenicity of a hexavalent group B streptococcus vaccine when administered concomitantly with Tetanus, Diphtheria, and Acellular Pertussis Vaccine (TDAP)
Participants will be placed in 1 of 3 study groups and may receive an investigational drug or a placebo with no affect. This trial will be 3 visits over the period of six months.
- Be a healthy non-pregnant woman, 19 through 49 years of age
- Other criteria may apply*
*Eligibility for studies may require specific demographics such as age and/or symptoms.
Eligible candidates will be compensated for time and travel.
To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our contact page.